Current and historical daily PE Ratio for Royalty Pharma PLC (
) from 2020 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Royalty Pharma PLC stock (RPRX) PE ratio as of Apr 27 2024 is 11.11.
More Details
Royalty Pharma PLC (RPRX) PE Ratio (TTM) Chart
Royalty Pharma PLC (RPRX) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 974
- 1
- 2
- 3
- 4
- 5
- 6
- 11
Royalty Pharma PLC PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-04-28 | 11.1 | 2024-02-23 | 12.3 |
2024-04-26 | 11.1 | 2024-02-22 | 12.3 |
2024-04-25 | 11.2 | 2024-02-21 | 12.4 |
2024-04-24 | 11.1 | 2024-02-20 | 12.0 |
2024-04-23 | 11.0 | 2024-02-16 | 11.9 |
2024-04-22 | 11.0 | 2024-02-15 | 11.9 |
2024-04-19 | 11.2 | 2024-02-14 | 11.6 |
2024-04-18 | 11.1 | 2024-02-13 | 11.6 |
2024-04-17 | 11.0 | 2024-02-12 | 11.5 |
2024-04-16 | 10.9 | 2024-02-09 | 11.6 |
2024-04-15 | 11.2 | 2024-02-08 | 11.4 |
2024-04-12 | 11.2 | 2024-02-07 | 11.6 |
2024-04-11 | 11.5 | 2024-02-06 | 12.0 |
2024-04-10 | 11.7 | 2024-02-05 | 11.0 |
2024-04-09 | 11.8 | 2024-02-02 | 11.2 |
2024-04-08 | 11.6 | 2024-02-01 | 11.4 |
2024-04-05 | 11.6 | 2024-01-31 | 11.3 |
2024-04-04 | 11.4 | 2024-01-30 | 11.4 |
2024-04-03 | 11.4 | 2024-01-29 | 11.5 |
2024-04-02 | 11.7 | 2024-01-26 | 11.6 |
2024-04-01 | 11.9 | 2024-01-25 | 11.6 |
2024-03-28 | 12.1 | 2024-01-24 | 11.5 |
2024-03-27 | 12.1 | 2024-01-23 | 11.7 |
2024-03-26 | 12.0 | 2024-01-22 | 11.6 |
2024-03-25 | 12.0 | 2024-01-19 | 11.5 |
2024-03-22 | 12.0 | 2024-01-18 | 11.1 |
2024-03-21 | 12.1 | 2024-01-17 | 11.2 |
2024-03-20 | 12.1 | 2024-01-16 | 11.3 |
2024-03-19 | 12.0 | 2024-01-12 | 11.3 |
2024-03-18 | 11.9 | 2024-01-11 | 11.3 |
2024-03-15 | 11.9 | 2024-01-10 | 11.4 |
2024-03-14 | 11.8 | 2024-01-09 | 11.2 |
2024-03-13 | 11.9 | 2024-01-08 | 11.1 |
2024-03-12 | 12.0 | 2024-01-05 | 10.9 |
2024-03-11 | 11.9 | 2024-01-04 | 11.0 |
2024-03-08 | 12.1 | 2024-01-03 | 11.0 |
2024-03-07 | 11.9 | 2024-01-02 | 11.2 |
2024-03-06 | 11.8 | 2023-12-29 | 11.2 |
2024-03-05 | 11.7 | 2023-12-28 | 11.1 |
2024-03-04 | 11.9 | 2023-12-27 | At Loss |
2024-03-01 | 11.9 | 2023-12-26 | At Loss |
2024-02-29 | 12.0 | 2023-12-22 | At Loss |
2024-02-28 | 12.2 | 2023-12-21 | At Loss |
2024-02-27 | 12.4 | 2023-12-20 | At Loss |
2024-02-26 | 12.4 | 2023-12-19 | At Loss |
Royalty Pharma PLC (RPRX) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Royalty Pharma PLC
NAICS : 541714
SIC : 2833
ISIN : GB00BMVP7Y09
Description